• Susanne Meghdadpour and Njira L Lugogo.
• Division of Pulmonary, Department of Pediatrics, Allergy and Sleep Medicine, Duke University, Durham, North Carolina.
• Respir Care. 2018 Jun 1; 63 (6): 759-772.

AbstractGuideline-based management of asthma was developed as a means of standardizing asthma therapies and of improving outcomes. The National Asthma Education and Prevention Program and the Global Initiative for Asthma guidelines provide recommendations to care providers about the routine management of asthma. There has been rapid development of new therapies for asthma, specifically with the advent of new drug delivery devices and biologic therapies for severe asthma. We are increasingly recognizing that asthma is a heterogenous disease with a diverse underlying pathophysiology, and therefore, it is imperative for care providers to begin to understand asthma phenotypes and endotypes, and the implications of these classifications on management, especially of severe refractory asthma. This article serves as a review of guideline-based therapy for asthma and includes updates on alternative therapies, new approaches that use previously recognized therapies, and special populations with asthma.Copyright © 2018 by Daedalus Enterprises.

10 keywords...

hide…